Pneumonia in Older Adults: An Update
|
|
- Tyler Goodman
- 6 years ago
- Views:
Transcription
1 Pneumonia in Older Adults: An Update Suzanne F. Bradley, M.D. Professor of Internal Medicine Geriatrics & Infectious Diseases University of Michigan Medical School GRECC - VA Ann Arbor HCS
2 ID Hospitalizations Diagnoses - > 65 yrs LRTI Urinary Sepsis Cellulitis Prosthetic Other Curns et al. Arch Intern Med 2005;165:2514.
3 ID Deaths Diagnoses - > 65 yrs LRTI Urinary Sepsis Cellulitis Prosthetic Other 6.2 Curns et al. Arch Intern Med 2005;165:2514.
4 Pneumonia in Older Adults Update Risk factors What is modifiable? Treatment in LTCF CAP vs HCAP Oral care - is it the key? Impact of vaccinating other populations More antigen = a better vaccine? New causes - all pneumonia isn t bacterial Improving surveillance in LTCF
5 Pneumonia-Older Adults Risk Factors Exposure Pathogens Altered Flora RTI Altered Clearance Cough Gastric Acid Swallowing Altered Immunity
6 Pneumonia - Older Adults Infection Control Effect Drugs Rapid Dx Oral Care Disinfectants Probiotics RTI Positioning Feeding approach Substance P Suctioning Vaccination Appropriate Rx
7 Empiric Rx IDSA (2003) CAP NH Hospital Nursing Home Pneumonia Rx 3 Guidelines = No Consensus oral quinolone or amox/clav + macrolide IV 3 rd ceph or amox/sulbactam + macrolide or quinolone Mylotte JM. Clin Geriatr Med 2007;23:553. CIDS (2000) CAP oral quinolone or 2 nd ceph + macrolide IV quinolone or IV 2 nd -4 th cephs + macrolide ATS/IDSA (2005) HCAP NA 3 rd -4 th cephs carbepenem or pip/tazo + cipro & vanco or linezolid
8 NHAP in Hospital CAP vs HCAP Rx 334 pts at 3 Buffalo hospitals Retrospective analysis Difference HCAP (n=76) vs CAP (n=258), p<.001 longer LOS, longer time to oral rx No difference co-morbidities, function, PSI, BSI, multilobar time to Ab, vaccines, O2 assessment time to clinical stability, 30 day mortality El Solh A et al. JAGS 2009;57:1030.
9 Pneumonia-Older Adults Modifiable Risk Factors 1 yr surveillance 5 NH (n=613) CXR proven pneumonia Inadequate HR (95% CI) P value* Oral care 1.55 ( ) 0.03 Swallowing 1.61 ( ) 0.43 * COPD, age, NH, immobility, co-morbidities Not significant flu vaccine, sedatives, smoking, acid reduction rx, feeding position, ace inhibitor Quagliarello V et al. Clin Infect Dis 2005;4:1-6.
10 Oral Hygiene for Older Adults Pneumonia/LRTI Rates/Deaths RCT Intervention ARR (95% CI CHX post op 6.6 ( ) Brushing/1% povidone 7.3 (0-14.6) Brushing/1% povidone 11.3 ( ) Professional cleaning q wk 11.7 ( ) Sjogren P et al. JAGS 2008;56:2124.
11 Pneumonia in NH Pts Oral Hygiene/Swallowing Manual oral brushing reduce bacterial pathogens, increase substance P, improve swallowing NH Rx by CNAs feasibility (%) oral brushing fluoride paste x 2 minutes (100%) chlorhexidine 0.12% rinse x 2 minutes (100%) upright feeding position 90 x min (95%) chin tuck feeding position when assisted (48%) significant improvement plaque score by 3 mo Quagliarello V et al. JAGS 2009;57:1226.
12 Changes in Overall Invasive Pneumococcal Disease, Cases/100,000 population PCV7 introduced Age Group (years) < vs baseline (% reduction) i Pilishvili T et al. J Infect Dis 2010;201:32. Year et al. J Infect Dis. 2010;2P01:32-41.
13 Invasive Pneumococcal Disease Penicillin Non-susceptible Kyaw M et al. NEJM 2006;354:1455. Kyaw M, et al. N Engl J Med. 2006;354:
14 Invasive Pneumococcal Disease Serotype 19A Moore M et al. J Infect Dis 2008;197:1016. Moore M, et al. J Infect Dis. 2008;197:
15 IPD and S. pneumoniae Serotypes Children < 5 years Adults > 50 years Moore M et al. J Infect Dis 2008;197:1016. Moore M, et al. J Infect Dis. 2008;197: White bars: penicillin susceptible; gray bars: penicillin intermediate; black bars: penicillin resistant
16 Pneumococcal Polysaccharide Vaccine (PPV23) Single dose recommended for: All 65 years 2 64 years (immunocompromised hosts): diabetes, chronic cardiovascular, pulmonary, liver disease alcoholism, CSF leaks, asplenia, cochlear implants Asthmatics and smokers age years One-time revaccination (proposed): 5 years after the first dose immunocompromised hosts 2-64 yrs ACIP CDC ACIP Schedules. Accessed September CDC. Accessed Oct 2009.
17 H1N1 Pandemic Influenza Deaths Bacterial Pneumonia (29%) A B Bacteria Number of Cases S. pneumoniae 10 S. aureus 7 S. pyogenes 6 S. mitis 2 H. influenzae 1 Multiple pathogens 4 Histochemical and Immunohistochemical diagnosis of S. pneumoniae infection A: Lillie-Twort Gram stain of lung tissue B: Immunohistochemical staining of multiple S. pneumoniae CDC. MMWR Morb Mortal Wkly Rep. 2009;58(38):
18 Pneumonia in Older Adults Influenza Vaccine High-dose Inactivated Vaccine Trivalent injectable FDA approved > 65 yrs 60 µg vs 15 µg HA per strain Higher antibody titers local injection reactions 36% vs 24% fever 1.1% vs 0.3%? protective flu or pneumonia not known no recommendation re use Falsey AR et al. J Infect Dis 2009;2009;200:172; MMWR 59:485, 2010.
19 Outbreaks in LTCF Non-Influenzal Illness Virus Attack LRTI Transfer Death Culture RT-PCR Rate % % % Rate % (+) (+) RSV /22 7/22 hmpv /13 0/20 6/13 5/14 Rhinovirus /13 4/10 6/19 7/13 Caram LB et al., JAGS 2009;57:482.; Boivin G et al. CID 2007;44:1152.; Louie JK et al. CID 2007;196:705.; Hicks LA et al., JAGS 2006;54:284.
20 Pneumonia in LTCF Can We Improve Surveillance? Revising McGeer definitions - 1st draft SHEA LTCF SIG/CDC systematic review literature National surveillance system for LTCF establish benchmarks assess impact of interventions performance improvement
21 Revising McGeer Draft Definitions CXR + pneumonia or new infiltrate and At least one respiratory criterion and new or worse sputum or cough 02 sat < 94% on RA or <3% from baseline new or changed lung exam pleuritic chest pain RR > 25 breaths per min
22 Revising McGeer Draft Definitions At least one constitutional sign/sx and fever > 37.8 C (100 F) orally leukocytosis > 14K or left shift > 6% or 1.5K acute change in MS/function Absence of another cause (CHF) McGeer A et al. Am J Infect Control 1991;19:1.
23 Pneumonia in Older Adults Summary Common infection & severe outcome Optimal Rx NHAP debated Focus on oral care for prevention Vaccination other populations effective Newer vaccines coming NH pneumonia surveillance will help define the extent of the problem target areas for intervention baseline for reassessment and improvement
ACIP Recommendations for Pneumococcal 13-valent Conjugate and 23-valent Polysaccharide Vaccine Use among Adults
ACIP Recommendations for Pneumococcal 13-valent Conjugate and 23-valent Polysaccharide Vaccine Use among Adults National Center for Immunization & Respiratory Diseases Respiratory Diseases Branch ACIP
More informationRecommendations for Using Pneumococcal Vaccines among Adults
Recommendations for Using Pneumococcal Vaccines among Adults AI Collaborative Webinar July 2017 Tamara Pilishvili Respiratory Diseases Branch, CDC National Center for Immunization & Respiratory Diseases
More informationRecommendations for Using Pneumococcal Vaccines among Adults
Recommendations for Using Pneumococcal Vaccines among Adults AI Collaborative Webinar February 2016 Tamara Pilishvili Respiratory Diseases Branch, CDC National Center for Immunization & Respiratory Diseases
More informationThis continuing education activity is co-sponsored by USF Health and by CME Outfitters, LLC.
This continuing education activity is co-sponsored by USF Health and by CME Outfitters, LLC. USF Health and CME Outfitters, LLC, gratefully acknowledge an educational grant from Pfizer Inc. in support
More informationUpper...and Lower Respiratory Tract Infections
Upper...and Lower Respiratory Tract Infections Robin Jump, MD, PhD Cleveland Geriatric Research Education and Clinical Center (GRECC) Louis Stokes Cleveland VA Medical Center Case Western Reserve University
More informationPneumococcal pneumonia
Pneumococcal pneumonia Wei Shen Lim Consultant Respiratory Physician & Honorary Professor of Medicine Nottingham University Hospitals NHS Trust University of Nottingham Declarations of interest Unrestricted
More informationDisclosures. Case 1. Acute Bronchitis. Acute Bronchitis. Community-Acquired Pneumonia and other Respiratory Tract Infections. What do you recommend?
Community-Acquired Pneumonia and other Respiratory Tract Infections none Disclosures Joel T. Katz, M.D. Associate Professor of Medicine Division of Infectious Diseases Brigham and Women s Hospital Case
More information9/12/2018. Pneumococcal Disease and Pneumococcal Vaccines. Streptococcus pneumoniae. Pneumococcal Disease. Adult Track. Gram-positive bacteria
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Pneumococcal Disease and Pneumococcal Vaccines Adult Track Chapter 17 Photographs and images included
More informationHaemophilus influenzae
Haemophilus influenzae type b Severe bacterial infection, particularly among infants During late 19th century believed to cause influenza Immunology and microbiology clarified in 1930s Haemophilus influenzae
More information7/13/2016. Immunization Update Disclosures. Objectives. No financial disclosures to report
Immunization Update 2016 Courtney A. Robertson, PharmD Clinical Assistant Professor University of Louisiana at Monroe School of Pharmacy Disclosures No financial disclosures to report Objectives Pharmacists
More informationEvelyn A. Kluka, MD FAAP November 30, 2011
Evelyn A. Kluka, MD FAAP November 30, 2011 > 80% of children will suffer from at least one episode of AOM by 3 years of age 40% will have > 6 recurrences by age 7 years Most common diagnosis for which
More informationGuidelines/Guidance/CAP/ Hospitalized Child. PHM Boot Camp 2014 Jay Tureen, MD June 19, 2014
Guidelines/Guidance/CAP/ Hospitalized Child PHM Boot Camp 2014 Jay Tureen, MD June 19, 2014 CAP in Children: Epi Greatest cause of death in children worldwide Estimated > 2 M deaths in children In developed
More information11/17/2013 THE WHO, WHAT, WHEN, AND WHY OF ADULT VACCINATIONS. Pneumococcal Vaccines for Adults (PPV) Pneumococcal Vaccines
THE WHO, WHAT, WHEN, AND WHY OF ADULT VACCINATIONS CAROL A. KAUFFMAN, MD VA ANN ARBOR HEALTHCARE SYSTEM UNIVERSITY OF MICHIGAN Will discuss: bacterial vaccines made of toxoids or polysaccharide capsular
More informationStreptococcus pneumoniae CDC
Streptococcus pneumoniae CDC Pneumococcal Disease Infection caused by the bacteria, Streptococcus pneumoniae» otitis media 20 million office visits (28-55% Strep)» pneumonia 175,000 cases annually» meningitis
More informationPneumonia Community-Acquired Healthcare-Associated
Pneumonia Community-Acquired Healthcare-Associated Edwin Yu Clin Infect Dis 2007;44(S2):27-72 Am J Respir Crit Care Med 2005; 171:388-416 IDSA / ATS Guidelines Microbiology Principles and Practice of Infectious
More informationAdult Immunization Update 2015
Adult Immunization Update 2015 Objectives Upon completion of this session, the pharmacist should be able to: Compare and contrast previous versions of the ACIP immunization schedules with the most recent
More informationOREGON PUBLIC HEALTH, DHS IMMUNIZATION PROTOCOL FOR PHARMACISTS. PNEUMOCOCCAL POLYSACCHARIDE VACCINE 23-Valent Vaccine
OREGON PUBLIC HEALTH, DHS IMMUNIZATION PROTOCOL FOR PHARMACISTS PNEUMOCOCCAL POLYSACCHARIDE VACCINE 23-Valent Vaccine Revisions as of 2/24/10 Pneumovax 23 should not be given concurrently with Zostavax
More informationPneumonia 2017 OMAR PIRZADA
Pneumonia 2017 OMAR PIRZADA Pneumonia Pneumonia is common 0.5-1% of adults per year, 5-12% presenting to GP with LRTi 22-42% will be admitted to hospital Symptoms and signs Case 1 26 year old man Sudden
More informationUpdate on Adult Immunization Strategies: Understanding the Current Recommendations
Update on Adult Immunization Strategies: Understanding the Current Recommendations EDWARD A. DOMINGUEZ, MD, FACP, FIDSA Medical Director, Organ Transplant Infectious Diseases Methodist Dallas Medical Center,
More informationKenneth McCall, BSPharm, PharmD Associate Professor UNE
Kenneth McCall, BSPharm, PharmD Associate Professor UNE Objectives Discuss the gap between current rates and Healthy People 2020 goals for vaccinations. Categorize each of the CDC recommended flu vaccines
More informationPneumococcal Disease and Pneumococcal Vaccines
Pneumococcal Disease and Epidemiology and Prevention of - Preventable Diseases Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at
More informationJon Temte, MD/PhD Chair Wisconsin Council on Immunization Practices Professor of Family Medicine and Community Health
Jon Temte, MD/PhD Chair Wisconsin Council on Immunization Practices Professor of Family Medicine and Community Health University of Wisconsin School of Medicine and Public Health Grand Rounds September
More informationIncidence per 100,000
Streptococcus pneumoniae Surveillance Report 2005 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services Updated: March 2007 Background
More informationPneumococcal vaccines
Pneumococcal vaccines Marco Aurélio Sáfadi, MD, PhD FCM da Santa Casa de São Paulo Challenges in establishing the baseline burden of disease, before implementing a vaccination program S. pneumoniae disease
More informationPneumococcal Vaccination. Bottom Line. Gangrene from Pneumococcal Bacteremia
Vaccination MSHO Performance Improvement Project Kristin L. Nichol, MD, MPH, MBA Professor of Medicine, University of Minnesota Chief of Medicine, Minneapolis VA Medical Cente Chair, MCAI Bottom Line disease
More informationStreptococcus pneumoniae
Streptococcus pneumoniae EPIDEMIOLOGY AND PREVENTION 2^4. November 2007 Prof. Dr. Kathrin Mühlemann Klinik und Poliklinik für Infektionskrankheiten Universität Bern, INSELSPITAL S. pneumoniae: epidemiology
More informationRespiratory Syncytial Virus (RSV) in Older Adults: A Hidden Annual Epidemic. Webinar Agenda
Respiratory Syncytial Virus (RSV) in Older Adults: A Hidden Annual Epidemic Wednesday, November 2, 2016 12:00 PM ET Webinar Agenda Agenda Welcome and Introductions William Schaffner, MD, NFID Medical Director
More informationPNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID
PNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID Objectives of Lecture Know the quality of current evidence based guidelines on immunization Appreciate the performance of pneumonia vaccines in terns
More informationThese slides are the property of the presenter. Do not duplicate without express written consent.
Cancer Survivorship Protecting Against Vaccine Preventable Diseases Heidi Loynes BSN, RN Immunization Nurse Educator Michigan Department of health and Human Services (MDHHS) loynesh@michigan.gov Are Vaccine-Preventable
More informationUse of 13-valent Pneumococcal Conjugate Vaccine and 23-valent Polysaccharide Vaccine in Adults with Immunocompromising Conditions
Use of 13-valent Pneumococcal Conjugate Vaccine and 23-valent Polysaccharide Vaccine in Adults with Immunocompromising Conditions Tamara Pilishvili, MPH Respiratory Diseases Branch National Center for
More informationCLAIRE NOWLAN & SAM SEARLE. Pneumonia in the nursing home
CLAIRE NOWLAN & SAM SEARLE Pneumonia in the nursing home No disclosures or conflicts of interest PMHX: A. FIB. GERD MIXED DEMENTIA MMSE 16/30 HTN Mr. Hack 86 years old RAMIPRIL 4 MG OD PARIET 20MG OD DONEPEZIL
More informationRecommended Vaccinations for Patients with Chronic Lung Disease RORY JOHNSON, PHARM.D., AE C ASSISTANT PROFESSOR UNIVERSITY OF MONTANA
Recommended Vaccinations for Patients with Chronic Lung Disease RORY JOHNSON, PHARM.D., AE C ASSISTANT PROFESSOR UNIVERSITY OF MONTANA Disclosures Nothing to Disclose Learning Objectives At the conclusion
More informationAntimicrobial Stewardship in Community Acquired Pneumonia
Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis
More informationPneumonia in the Hospitalized
Pneumonia in the Hospitalized Patient: Use of Steroids Nicolette Myers, MD Pulmonary/Sleep/Critical Care November 9, 2018 Park Nicollet Clinic Facts About Pneumonia CAP is the 8 th most common cause of
More informationSusan J. Rehm, MD, FACP, FIDSA Department of Infectious Disease Cleveland Clinic Cleveland, OH
Improving Adult Vaccination Practices Preventing Pneumococcal Disease in Your High-Risk and Older Patients Susan J. Rehm, MD, FACP, FIDSA Department of Infectious Disease Cleveland Clinic Cleveland, OH
More information2013 Adult Immunization Update. David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle
2013 Adult Immunization Update David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle Adult Immunization Update Pertussis Vaccine Influenza Vaccine Zoster
More informationInfection Prevention and Control in Long Term Care Part 2
Infection Prevention and Control in Long Term Care Part 2 Course ID: 1029 - Credit Hours: 2 Author(s) Bonnie Chustz,RN, BSN WCC Disclosures None Accreditation KLA Education Services LLC is accredited by
More informationHow do we define pneumonia?
Robert L. Keith MD FCCP Associate Professor of Medicine Division of Pulmonary Sciences & Critical Care Medicine Denver VA Medical Center University of Colorado Denver How do we define pneumonia? Fever
More informationBradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF -- William Osler, M.D.
Bradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu a. An ailment that often leads to suffocation and death. b. A friend of the aged. c. A common
More informationBradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF
Maximizing Care for Community- Acquired Pneumonia Bradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu 1. In 1898, William Osler described community-acquired
More informationMulti-drug Resistant Serotype 19A Pneumococci in Toronto
TML Lab Rounds January 17, 2008 Multi-drug Resistant Serotype 19A Pneumococci in Toronto The Role of the Microbiology Lab Susan M. Poutanen, MD, MPH, FRCPC Microbiologist/ID Consultant, TML/MSH Assistant
More informationvaccination. Children enrolled in these clusters between 6 weeks and 6 months of age received a 2-dose primary vaccination schedule.
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationWhat s New in Flu? An Update on Influenza Prevention and Treatment
What s New in Flu? An Update on Influenza Prevention and Treatment Kathryn M. Edwards MD Sarah H. Sell and Cornelius Vanderbilt Professor of Pediatrics Vanderbilt University Nashville, TN, USA Disclosures
More informationCall-to-Action: Recognizing the Burden of Vaccine- Preventable Diseases
Call-to-Action: Recognizing the Burden of Vaccine- Preventable Diseases Burden of Vaccine-Preventable Diseases Each Year 200,000 hospitalizations due to influenza As many as 36,000 deaths 29,100 cases
More informationVaccines for Primary Care Pneumococcal, Shingles, Pertussis
Vaccines for Primary Care Pneumococcal, Shingles, Pertussis Devang Patel, M.D. Assistant Professor Chief of Service, MICU ID Service University of Maryland School of Medicine Pneumococcal Vaccine Pneumococcal
More informationDR MOSES MWANGI HSC Regional Manager, Sanofi pasteur Eastern Africa
IINFLUENZAE & PNEUMOCOCCAL DISEASES,A CASE FOR PREVENTIVE APPROACH THROUGH VACCINATION AE & PNEUMO VACCINES ARE ESSENTAL PILLARS DR MOSES MWANGI HSC Regional Manager, Sanofi pasteur Eastern Africa 1 1
More informationUPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES
DISCLOSURES UPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES Nothing to disclose Kylie Mueller, Pharm.D., BCPS Clinical Specialist, Infectious Diseases Spartanburg Regional Medical Center LEARNING OBJECTIVES
More informationImpact of vaccination on epidemiology in adults
Impact of vaccination on epidemiology in adults Jan Verhaegen 1. Data on prospective study on IPD in Belgium (2009-2011) 2. Evolution of capsular types of invasive isolates from adults after introduction
More informationDisclosure Statement. Encapsulated Bacteria. Functions of the Spleen 10/25/2017. Pharmacist Learning Objectives
Pharmacist Learning Objectives No Spleen? No Problem. A Review of Vaccinations Indicated for the Asplenic Patient SCSHP Fall Meeting October 26, 2017 Explain the rationale for vaccinations in Select the
More informationPediatric and Adolescent Infectious Disease Concerns
Pediatric and Adolescent Infectious Disease Concerns Sean P. Elliott, MD Professor of Pediatrics Associate Chair of Education, Department of Pediatrics University of Arizona College of Medicine Tucson,
More informationExperience with maternal pertussis and PCV13 immunisation in England
Experience with maternal pertussis and PCV13 immunisation in England Immunisation, Hepatitis & Blood Safety department Public Health England 5th RIVM Vaccine Preventable Diseases Research day 18 th November
More informationKAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA
KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA Methodology: Expert opinion Issue Date: 8-97 Champion: Pulmonary Medicine Most Recent Update: 6-08, 7-10, 7-12 Key Stakeholders: Pulmonary Medicine,
More informationOutline. The Rule of Thirds. Basic Principles about Nursing Home Residents and Respiratory Disease. Bad Teeth and Lung Disease
Respiratory Infections in Nursing Homes Philip D. Sloane, MD, MPH Elizabeth and Oscar Goodwin Distinguished Professor of Family Medicine Co Director, Program on Aging, Disability, and Long Term Care, Cecil
More informationDiagnosis of Pneumococcal Disease
Diagnosis of Pneumococcal Disease Limitations of Surveillance for Invasive Disease David Murdoch University of Otago, Christchurch New Zealand Key Points We are still reliant on culture-based methods for
More informationINFLUENZA AND OTHER RESPIRATORY VIRUSES
INFLUENZA AND OTHER RESPIRATORY VIRUSES Lung Foundation Australia Patient Seminar 21 st October 2017 Lynette Reid Respiratory Clinical Nurse Specialist, RHH What is influenza (the flu )? Influenza (flu)
More informationPNEUMONIA. I. Background 6 th most common cause of death in U.S. Most common cause of infection related mortality
Page 1 of 8 September 4, 2001 Donald P. Levine, M.D. University Health Center Suite 5C Office: 577-0348 dlevine@intmed.wayne.edu Assigned reading: pages 153-160; 553-563 PNEUMONIA the most widespread and
More informationBrice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine
Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine Discuss advances in predicting prognosis Understand dwhat we know (and don t know) about the Microbiology Recognize important
More informationChapter 16 Pneumococcal Infection. Pneumococcal Infection. August 2015
Chapter 16 16 PPV introduced for at risk 1996 PCV7 introduced for at risk 2002 and as routine 2008 PCV13 replaced PCV7 in 2010 NOTIFIABLE In some circumstances, advice in these guidelines may differ from
More informationRespiratory Infections in Nursing Homes
Respiratory Infections in Nursing Homes Philip D. Sloane, MD, MPH Elizabeth and Oscar Goodwin Distinguished Professor of Family Medicine Co Director, Program on Aging, Disability, and Long Term Care, Cecil
More informationImmunization Update: New CDC Recommendations. Blaise L. Congeni M.D. 2012
Immunization Update: New CDC Recommendations Blaise L. Congeni M.D. 2012 Polysaccharide Vaccines Vaccine Hib capsule polysaccharide PRP (polyribose ribitol phosphate) Not protective in infants
More informationOverview of the Influenza Virus
Overview of the Influenza Virus Victor C. Huber, Ph.D. September 24, 2015 victor.huber@usd.edu General Features of Influenza Virus Infections Clinical Features of Influenza Sudden onset of symptoms Incubation
More informationCharles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center
Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center Kathy Peters is a 63 y.o. patient that presents to your urgent care office today with a history
More informationViral Threat on Respiratory Failure
Viral Threat on Respiratory Failure Younsuck Koh, MD, PhD, FCCM Department of Pulmonary and Critical Care Medicine Asan Medical Center University of Ulsan College of Medicine Seoul, Korea No Conflict of
More informationAdult Pneumococcal Disease
Adult Pneumococcal Disease S. pneumoniae and pneumococcal disease The bacterium Streptococcus pneumoniae causes pneumococcal disease S. pneumoniae is commonly found in human nasopharynx (nose and throat)
More informationInfluenza A 6/23/2010. Lisa Winston, MD UCSF / San Francisco General Hospital Divisions of Infectious Diseases and Hospital Medicine
Influenza Update in a Pandemic Year Nothing to disclose. Lisa Winston, MD UCSF / San Francisco General Hospital Divisions of Infectious Diseases and Hospital Medicine Influenza Biology Influenza Biology
More informationIn Case of Technical Difficulties
In Case of Technical Difficulties If you hear an echo: -- Make sure you are only logged in once on your computer -- Select one form of audio only (either computer speakers or telephone connection) If the
More informationRespiratory Tract Infec1ons Long Term Care. Dr Karsten Hammond Infec1ous Diseases 28 March 2015
Respiratory Tract Infec1ons Long Term Care Dr Karsten Hammond Infec1ous Diseases 28 March 2015 Disclosures I have no financial rela1onships to disclose 82 yo Female In LTC for two years, total care from
More informationACTIVITY DESCRIPTION Target Audience Learning Objectives
ACTIVITY DESCRIPTION Target Audience This activity is designed as a comprehensive approach to address the practice needs of primary care providers, including primary care physicians, doctors of osteopathy,
More informationACTIVITY DESCRIPTION Target Audience Learning Objectives
ACTIVITY DESCRIPTION Target Audience This activity is designed as a comprehensive approach to address the practice needs of primary care providers, including primary care physicians, doctors of osteopathy,
More information1/30/2016 RESPIRATORY INFECTIONS AND ASTHMA NO DISCLOSURES NO FINANCIAL INTEREST INFORMATION OBTAINED JACI AJRCCM
RESPIRATORY INFECTIONS AND ASTHMA NO DISCLOSURES NO FINANCIAL INTEREST INFORMATION OBTAINED JACI AJRCCM 1 2 year old male HISTORY -Daycare since 9 months of age -Recurrent symptoms since 10 months of age:
More informationOutline. Cryptococcosis Pneumocystosis Diarrhea. Case Histories: HIV Related- Opportunistic Infections in 2015
AU Edited: 05/06/15 Case Histories: HIV Related- Opportunistic Infections in 2015 Henry Masur, MD Clinical Professor of Medicine George Washington University School of Medicine Bethesda, Maryland Washington,
More informationCommunity-Acquired Pneumonia. Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital. Nothing to disclose.
Community-Acquired Pneumonia Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Nothing to disclose. Community-Acquired Pneumonia Talk will focus on adults Guideline
More informationUpdate on Adult Immunization Strategies: Understanding the Current Recommendations
Sunday CME Breakfast Update on Adult Immunization Strategies: Understanding the Current Recommendations Edward Dominguez, MD Medical Director, Organ Transplant Infectious Diseases Methodist Dallas Medical
More informationAdult Pneumococcal Disease
Adult Pneumococcal Disease S. pneumoniae and pneumococcal disease The bacterium Streptococcus pneumoniae causes pneumococcal disease S. pneumoniae is commonly found in human nasopharynx (nose and throat)
More informationMaternal Immunization Efficacy and Safety Saad B. Omer
Maternal Immunization Efficacy and Safety Saad B. Omer William H. Foege Professor of Global Health Professor of Epidemiology & Pediatrics Emory University, Schools of Public Health & Medicine Pregnancy
More informationPneumococcal: Disease & Vaccine
Pneumococcal: Disease & Vaccine Wednesday 15 June 2016 Wednesday 28 June 2016 Start time in your state: 7:30pm = QLD, NSW, VIC, TAS, ACT 7:00pm = SA, NT 5:30pm = WA Your presenter tonight Angela Newbound,
More informationCommunity Acquired Pneumonia. Background & Rationale to North American Guidelines. Lionel Mandell MD FRCPC Brussels Belgium
Community Acquired Pneumonia Background & Rationale to North American Guidelines Lionel Mandell MD FRCPC Brussels Belgium Consider Impact of the disease Issues to reflect upon Impact of the Disease 3-4
More informationUpdate on Vaccine Recommendations. Objectives. Childhood Immunization Schedule At the Turn of the Century. New Horizons in Pediatrics April 30, 2017
Centers for for Disease Disease Control Control and and Prevention Prevention National Center for Immunization and Respiratory Diseases Update on Vaccine Recommendations New Horizons in Pediatrics April
More informationHaemophilus influenzae and its invisibility cloak. Anna Strain Virology Supervisor/VPD Reference Center Coordinator June 5, 2018
Haemophilus influenzae and its invisibility cloak Anna Strain Virology Supervisor/VPD Reference Center Coordinator June 5, 2018 Haemophilus influenzae Gram negative aerobic coccobacilli Pfeiffer s Bacillus-
More informationBRIEF CASE ACUTE PNEUMONIA RESPIRATORY TRACT INFECTIONS MAJOR VIRAL RESPIRATORY PATHOGENS WHAT SPECIMENS SHOULD BE SENT TO R/O VIRAL INFECTION?
RESPIRATORY TRACT INFECTIONS BRIEF CASE LABORATORY MEDICINE COURSE 2004 CLINICAL MICROBIOLOGY SERVICE WHAT IS THE DIFFERENTIAL? WHAT TESTS TO ORDER? INTERPRETATION & EVALUATION Dr. Preeti Pancholi 5-6237
More informationPotential public health impact of RSV vaccines. R. Karron December 2016
Potential public health impact of RSV vaccines R. Karron December 2016 1. RSV is The leading cause of hospitalization in infants and in many high-income countries; >2 million medical visits annually in
More informationCAP, HCAP, HAP, VAP. 1. In 1898, William Osler described community-acquired pneumonia as:
1. In 1898, William Osler described community-acquired pneumonia as: Brad Sharpe, M.D. Professor of Clinical Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu I have no relevant financial
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients
More informationAndrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases MCH & Immunization Conference Anchorage, AK September 28, 2010
2010 Immunization Update Andrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases MCH & Immunization Conference Anchorage, AK September 28, 2010 Disclosures No financial conflict
More informationCommunity Acquired Pneumonia
April 2014 References: 1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL Mace SE, McCracken Jr. GH, Moor MR, St. Peter SD, Stockwell JA, and Swanson JT. The Management of
More information2/16/2015 IMMUNIZATION UPDATE Kelly Ridgway, RPh February 21, Today s Overview NEW RECOMMENDATIONS
IMMUNIZATION UPDATE 2015 Kelly Ridgway, RPh February 21, 2015 Today s Overview 1 2 3 4 5 6 Pneumococcal Vaccine Recommendations Meningococcal Vaccine Recommendations HPV Vaccine Recommendations Patient
More informationsamedi 17 octobre 2009 MJA 2009, 191:142
1 MJA 2009, 191:142 2 MJA 2009, 191:142 3 4 CDC Interim Recommendations for Oseltamivir and Zanamivir Patient Categories for Treatment 1.Recommended: all patients hospitalized with suspected or confirmed
More informationOutline. Seasonal Influenza & Pneumonia National & State Statistics Novel Influenza A H1N1
Outline Seasonal Influenza & Pneumonia National & State Statistics Novel Influenza A H1N1 National & State Statistics Lessons from Past Pandemics Vaccination & Treatment Strategies Influenza Virus Influenza
More informationPEDIATRIC INFLUENZA CLINICAL PRACTICE GUIDELINES
PEDIATRIC INFLUENZA CLINICAL PRACTICE GUIDELINES DEFINITIONS AND BACKGROUND Uncomplicated influenza illness is characterized by the abrupt onset of constitutional and respiratory signs and symptoms. Signs
More informationPoint/Counterpoint. Mia A. Taormina, DO, FACOI MarkAlain Dery, DO, FACOI
Point/Counterpoint Mia A. Taormina, DO, FACOI MarkAlain Dery, DO, FACOI It s Influenza Season A couple in their 40s comes to your clinic in early August and asks about influenza vaccine. It is being offered
More informationDOES YOUR IMMUNIZATION KNOWLEDGE NEED A BOOSTER?: UPDATES FOR 2014
DOES YOUR IMMUNIZATION KNOWLEDGE NEED A BOOSTER?: UPDATES FOR 2014 Brandon Dionne, PharmD PGY2 Pharmacy Resident In Infectious Diseases University Of New Mexico College Of Pharmacy OBJECTIVES Explain general
More information10/4/2014 DOES YOUR IMMUNIZATION KNOWLEDGE NEED A BOOSTER?: UPDATES FOR 2014 OBJECTIVES CASE 1 IMMUNIZATION PRINCIPLES CASE 2
DOES YOUR IMMUNIZATION KNOWLEDGE NEED A BOOSTER?: UPDATES FOR 2014 Brandon Dionne, PharmD PGY2 Pharmacy Resident In Infectious Diseases University Of New Mexico College Of Pharmacy OBJECTIVES Explain general
More informationPneumonia: The Forgotten Killer
Pneumonia: The Forgotten Killer David Glenn Weismiller, MD, ScM, FAAFP Department of Family and Community Medicine University of Nevada, Las Vegas School of Medicine Disclosure Statement It is the policy
More informationExpanded Use of PCV13 & PPV23
Expanded Use of PCV13 & PPV23 Dr. Jim Kellner Professor & Head Department of Pediatrics University of Calgary & Calgary Zone, Alberta Health Services Jim.Kellner@ahs.ca Objectives Explain the differences
More informationInfluenza Prevention Update
Influenza Prevention Update Dean A. Blumberg, MD, FAAP Disclosure speakers bureau: sanofi pasteur, Merck Discussion off label use of FDA approved vaccines Influenza Prevention Update Seasonal influenza
More informationImmunizations are among the most cost effective and widely used public health interventions.
Focused Issue of This Month Recommended by the Korean Pediatric Society, 2008 Hoan Jong Lee, MD Department of Pediatrics, Seoul National University College of Medicine E mail : hoanlee@snu.ac.kr J Korean
More informationINFLUENZA VIRUS. INFLUENZA VIRUS CDC WEBSITE
INFLUENZA VIRUS INFLUENZA VIRUS CDC WEBSITE http://www.cdc.gov/ncidod/diseases/flu/fluinfo.htm 1 THE IMPACT OF INFLUENZA Deaths: PANDEMICS 1918-19 S p a n is h flu 5 0 0,0 0 0 U S 2 0,0 0 0,0 0 0 w o rld
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE
Last Updated: Version 4.4 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Immunization Set Measure ID#: Measure Information Form Collected For: CMS Voluntary Only The Joint Commission
More informationBacterial diseases caused by Streptoccus pneumoniae in children
Bacterial diseases caused by Streptoccus pneumoniae in children Bactermia 85% Bacterial pneumonia 66% Bacterial meningitis 50% Otitis media 40% Paranasal sinusitis 40% 0% 10% 20% 30% 40% 50% 60% 70% 80%
More information21 st Century Vaccine Challenges
21 st Century Vaccine Challenges Presentation by Rosalyn Singleton MD, ANTHC Slides adapted from original powerpoint by: Carrie L. Byington, MD HA and Edna Benning Presidential Professor of Pediatrics
More information